Short interest in Galectin Therapeutics Inc (NASDAQ:GALT) decreased during the last reporting period, falling from 6.82M to 5.95M. This put 13.06% of the company's publicly available shares short.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results